Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 1:198:88-91.
doi: 10.1016/j.amjcard.2023.03.034. Epub 2023 May 19.

Female Recruitment Into Cardiovascular Disease Trials

Affiliations

Female Recruitment Into Cardiovascular Disease Trials

Yingfei Wu et al. Am J Cardiol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors have no conflicts of interest to declare.

Figures

Figure 1.
Figure 1.
Distribution of female participants. (A) Distribution of female participants enrolled by time period. (B) Distribution of female participants enrolled by study type. (C) Distribution of female participants enrolled by intervention type. Arrhyth = arrhythmia; CAD = coronary artery disease; CVA = stroke/cerebrovascular; HF = heart failure; HLD = hyperlipidemia; HTN = hypertension.

References

    1. Cho L, Vest AR, O’Donoghue ML, Ogunniyi MO, Sarma AA, Denby KJ, Lau ES, Poole JE, Lindley KJ, Mehran R, Cardiovascular Disease in Women Committee Leadership Council. Increasing participation of women in cardiovascular trials: JACC council perspectives. J Am Coll Cardiol 2021;78:737–751. - PubMed
    1. Prasanna A, Miller HN, Wu Y, Peeler A, Ogungbe O, Plante TB, Juraschek SP. Recruitment of black adults into cardiovascular disease trials. J Am Heart Assoc 2021;10:e021108. - PMC - PubMed
    1. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Shay CM, Spartano NL, Stokes A, Tirschwell DL, VanWagner LB, Tsao CW, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke Statistics-2020 update: a report from the American Heart Association. Circulation 2020;141:E139–E596. - PubMed
    1. Jin X, Chandramouli C, Allocco B, Gong E, Lam CSP, Yan LL. Women’s participation in cardiovascular clinical trials from 2010 to 2017. Circulation 2020;141:540–548. - PubMed
    1. Melloni C, Berger JS, Wang TY, Gunes F, Stebbins A, Pieper KS, Dolor RJ, Douglas PS, Mark DB, Newby LK. Representation of women in randomized clinical trials of cardiovascular disease prevention. Circ Cardiovasc Qual Outcomes 2010;3:135–142. - PubMed

Publication types